Anastrozole
Product Images NDC 76519-1224

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 76519-1224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (76519 1224 Ppac Label)

Label (76519 1224 Ppac Label)
ANASTROZOLE 1mg TABLET is a medication used as directed by a physician. The drug is prohibited by federal law for anyone other than the prescribed person and cannot be dispensed without a prescription. The medication is compared to Arimidex and comes in a 1mg tablet form with different NDC and Exp. numbers. The drug must be kept out of the reach of children and stored in places ranging from 18 C to 25 C. The manufacturer is Mig. ACCORD with Rapack: H.J Harkin Co., In. located in Grover Beach, CA.*
FDA Label Image

Disimage (Disimage)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

Figure5 (Figure5)
This text seems to be a table showing different measured values for a treatment with two drugs, Anastrozole and Tamoxifen, on a process labeled FFOPORTICK. However, there isn't enough information in the text to determine what the measured values specifically indicate or what FFOPORTICK refers to.*
FDA Label Image

Figure6 (Figure6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.